Dividend-adjusted total return · Feb 1, 2007 – Nov 4, 2026RXL
| Returns | 1D | 1M | 3M | YTD | 1Y | 3Y | 5Y | MAX |
|---|---|---|---|---|---|---|---|---|
| Total return | +6.3% | +27.6% | +31.4% | +43.5% | +64.3% | +101.4% | +53.6% | +1,813.5% |
| Peer average | −0.9% | −24.0% | −15.1% | −2.7% | −5.0% | +116.4% | +53.4% | — |
| S&P 500 · VOO | +1.6% | −1.6% | 0.0% | +13.4% | +13.5% | +91.7% | +81.2% | — |
Key Statistics
Open all fund facts →- AUM
- $112M
- Expense ratio
- 1.08%
- Distribution yield
- 0.9%
- NAV
- $69.43
- Volume
- 34K
- Avg. volume 30D
- 13K
- High today
- $73.99
- Low today
- $70.58
- Previous close
- $69.32
- 52-week high
- $73.99
- 52-week low
- $42.76
- Our risk indicator
- 5/5
RXL in One Breath
RXL Among An Index ETFs
YTDEnd-of-day Nov 5, 2026 · 85 An index ETFs by YTD
$10,000 in RXL
5Y$10,000 in RXL became
$15,361
In the S&P 500 (VOO)
$18,115
Total return, dividends in · Oct 27, 2021 – Nov 4, 2026 · S&P 500 uses VOO
RXL’s Top Holdings
TodayIQMMProshares Genius Mny Mkt Etf13.3%LLY10.6%JNJ6.0%ABBV4.7%UNH3.4%MRK3.3%TMO2.4%AMGN2.3%GILD1.9%ABT1.8%PFE1.6%ISRG1.5%DHR1.3%VRTX1.3%BMY1.2%MDT1.1%CVSMCKSYKREGNELV48 more
IQMMProshares Genius Mny Mkt Etf13.3%LLY10.6%JNJ6.0%ABBV4.7%UNH3.4%MRK3.3%TMO2.4%AMGN2.3%GILD1.9%ABT1.8%PFEISRG58 more
Drug Manufacturers - GeneralAsset Management - BondsMedical - DiagnosticsMedical - Healthcare PlansMedical - DevicesBiotechnologyOther
ProShares RXL · 70 holdings · tile size = share of the fund · as of Nov 4, 2026
What RXL Holds
TodayDrug Manufacturers - General32.0%
LLY 10.6 · JNJ 6.0 · ABBV 4.7 · MRK 3.3 · AMGN 2.3 · GILD 1.9 · PFE 1.6
Asset Management - Bonds13.3%
IQMM 13.3
Medical - Diagnostics & Research7.1%
TMO 2.4 · DHR 1.3 · IDXX · A · WAT · IQV · ILMN
Medical - Healthcare Plans6.8%
UNH 3.4 · CVS 1.1 · ELV · CI · HUM · CNC
Medical - Devices6.0%
ABT 1.8 · MDT 1.1 · SYK 1.0 · BSX · EW · GEHC · DXCM
Biotechnology3.2%
VRTX 1.3 · REGN · MRNA · INCY · TECH
Other holdings31.4%
ISRG 1.5 · MCK 1.1 · HCA · COR · CAH · BDX · VEEV
ProShares RXL · share of the fund by industry · as of Nov 4, 2026
Proshares’ Share of RXL
Today13.3%
$133 of every $1,000 in RXL is Proshares
Proshares held by RXL
$15.0M
ProShares RXL · each square = $10 of $1,000 · as of Nov 4, 2026
RXL’s Share of An Index ETFs
Today0.1%
of the $136B in 404 An index ETFs
$112M0.1%
$32.5B23.9%
$18.0B13.3%
$85.1B62.7%
An index ETF AUM · Nov 5, 2026
RXL Fee per $100 vs Peers
TodayExpense ratio · An index peers · Nov 5, 2026
Inside RXL
70 holdings · as of Nov 4, 2026RXL
ProShares Ultra Health Care
TodayDrug Manufacturers - General32.0%LLYELI Lilly &10.6%JNJ6.0%ABBV4.7%MRK3.3%AMGN2.3%GILDPFEBMYAsset Management - Bonds13.3%IQMMProshares Genius MNY MKT ETF13.3%Medical - Diagnostics7.1%TMODHRIDXXAWATIQVILMNMTDLHDGXMedical - Healthcare Plans6.8%UNHCVSELVCIHUMMedical - Devices6.0%ABTMDTSYKBSXEWBiotechnology3.2%VRTXREGNMRNAOther31.4%ISRGMCKHCACORCAH9 more holdings25.5% of the fund
Drug Manufacturers - General32.0%LLY10.6%JNJ6.0%ABBV4.7%MRKAMGNGILD3 moreAsset Management - Bonds13.3%IQMM13.3%Medical - Diagnostics7.1%TMODHRIDXXAMedical - Healthcare Plans6.8%UNHCVSHUMMedical - Devices6.0%ABTMDTSYKBSXEWBiotechnology3.2%VRTXREGNOther31.4%ISRGMCKHCACORCAHBDX12 more holdings26.6% of the fund
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | IQMM | Proshares Genius MNY MKT ETF | 13.35% |
| 2 | LLY | ELI Lilly & | 10.56% |
| 3 | JNJ | Johnson & Johnson | 6.00% |
| 4 | ABBV | Abbvie | 4.73% |
| 5 | UNH | Unitedhealth Group | 3.40% |
| 6 | MRK | Merck & | 3.34% |
| 7 | TMO | Thermo Fisher Scientific | 2.42% |
| 8 | AMGN | Amgen | 2.33% |
| 9 | GILD | Gilead Sciences | 1.94% |
| 10 | ABT | Abbott Laboratories | 1.77% |
Drug Manufacturers - GeneralAsset Management - BondsMedical - DiagnosticsMedical - Healthcare PlansMedical - DevicesBiotechnologyOther
ProShares RXL · current holdings by weight · as of Nov 4, 2026 · each tile is one holding · top 20 = 61.9%
How It Compares
RXL
ProShares Ultra Health Care’s Peers
YTDAn index peers · YTD and past-year returns · as of Nov 5, 2026 · sorted by AUM
Head to Head
Put RXL head to head with QLD →QLD vs RXL
YTDYear to date
RXL wins+25.7 pts
Past year
RXL wins+54.3 pts
Fee
QLD winslower fee
Yield
RXL wins+0.7 pts
AUM
QLD116.9× more
3–1RXL wins
ProShares QLD and ProShares RXL · year-to-date · as of Nov 5, 2026 · AUM not scored
RXL vs VOO
YTDRXL · ProShares Ultra Health Care
+43.5%
VOO · S&P 500
+13.4%
Gap
30.1 pts
ProShares RXL and Vanguard VOO · YTD total return · as of Nov 5, 2026
RXL vs Its Peer Average
YTDRXLAvsBPeer average
1D+6.3%−0.9%
1M+27.6%−24.0%
3M+31.4%−15.1%
YTD+43.5%−2.7%
1Y+64.3%−5.0%
3Y+101.4%+116.4%
5Y+53.6%+53.4%
6–1RXL wins
229 An index peers · each row scaled to its leader
The Details
RXL
Risk
1Y5/5our risk indicator
CalmerBumpier
Volatility · 1Y33.24%
Deepest drop · 1Y−21.3%
Lowest point · 5Y−23.8%
52-week range
$73.67
$42.76−0.4% from the high$73.99
ProShares RXL · past-year price moves · as of Nov 5, 2026
RXL
Fund Facts
Today2007launched Jan 30
Tracks[…]
Exchange · CUSIPAMEX · 74347R735
StructureETF
Leverage2x
Cost on $10,000$108 a year
Go deeper
ProShares RXL · fund facts · as of Nov 5, 2026
RXL
Payouts by Year
13Y$0.13per share, Sep 2026
Distribution yield0.9%
PaidEvery quarter
Latest ex-date · paidSep 23 · Sep 29, 2026
12 payouts added up$1.81 a share
ProShares RXL · distributions by ex-date · 2014–2026
All Fund FactsDocuments · trading · fees · every payout
Prospectus & Documents
Trading & Liquidity
Net asset value$69.43
Premium / discount[…]
Median spread · 30D[…]
Volume today34K
Average volume · 30D13K
Shares outstanding[…]
Options[…]
Fees & Costs
Net expense ratio1.08%
Gross expense ratio[…]
Management fee[…]
Cost on $10,000 a year$108.00
Our risk indicator5/5
Estimated yearly cost excludes trading costs and assumes constant assets.
Distributions
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 23, 2026 | Sep 29, 2026 | $0.13 |
| Jun 24, 2026 | Jun 30, 2026 | $0.18 |
| Mar 25, 2026 | Mar 31, 2026 | $0.14 |
| Dec 24, 2025 | Dec 31, 2025 | $0.18 |
| Sep 24, 2025 | Sep 30, 2025 | $0.20 |
| Jun 25, 2025 | Jul 1, 2025 | $0.22 |
| Mar 26, 2025 | Apr 1, 2025 | $0.13 |
| Dec 23, 2024 | Dec 31, 2024 | $0.15 |
| Sep 25, 2024 | Oct 2, 2024 | $0.13 |
| Jun 26, 2024 | Jul 3, 2024 | $0.17 |
| Mar 20, 2024 | Mar 27, 2024 | $0.0860 |
| Dec 20, 2023 | Dec 28, 2023 | $0.0841 |
Issuer contentFrom ProSharesHear the strategy from the people behind RXL.No issuer videos have been published for this fund.Are you the issuer? Claim this fund →